EAM
TSVT

Erste Asset Management’s 2seventy bio TSVT Stock Holding History

Erste Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,999
Closed -$24.6K – 571
2024
Q3 		$24.6K Hold
4,999
– – ﹤0.01% 525
2024
Q2 		$18.8K Hold
4,999
– – ﹤0.01% 527
2024
Q1 		$26.9K Hold
4,999
– – ﹤0.01% 517
2023
Q4 		$22.9K Hold
4,999
– – ﹤0.01% 530
2023
Q3 		$18.9K Hold
4,999
– – ﹤0.01% 532
2023
Q2 		$49.9K Hold
4,999
– – ﹤0.01% 537
2023
Q1 		$49.4K Hold
4,999
– – ﹤0.01% 549
2022
Q4 		$44.8K Hold
4,999
– – ﹤0.01% 545
2022
Q3 		$70.3K Hold
4,999
– – ﹤0.01% 530
2022
Q2 		$65.9K Hold
4,999
– – ﹤0.01% 545
2022
Q1 		$86K Hold
4,999
– – ﹤0.01% 522
2021
Q4 		$134K Buy
+4,999
New +$156K ﹤0.01% 504

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return

Erste Asset Management's TSVT Position: Q4 2024 in Review

Erste Asset Management sold out of 2seventy bio (TSVT) in Q4 2024, closing a stake of 4,999 shares — an estimated $24.6K sold.

Erste Asset Management first reported a position in TSVT in Q4 2021 and held it in 12 quarters. The position peaked at $134K in Q4 2021. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2024.

  • Erste Asset Management reported no remaining 2seventy bio position as of Q4 2024 after selling out during the quarter.
  • Erste Asset Management sold 4,999 2seventy bio shares in Q4 2024, an estimated $24.6K.
  • Erste Asset Management first reported a position in 2seventy bio in Q4 2021 and held it in 12 quarters.
  • Erste Asset Management's 2seventy bio position peaked at $134K in Q4 2021.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2024.

Based on Erste Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.